Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

trifluridine tipiracil drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
trifluridine tipiracil drug combination
Unique ID
C000613803
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000613803
Entry Term(s)
Lonsurf
TAS 102
TAS-102
TAS102
trifluridine - tipiracil
trifluridine and tipiracil
trifluridine tipiracil
Registry Numbers
0
Heading Mapped to
Drug Combinations
*Pyrrolidines
*Thymine
*Trifluridine
Frequency
207
Note
trifluridine tipiracil combination for treatment of colorectal cancer; a 1:0.5 mixture of viroptic and 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil (5-CIMU); an antimetabolite with antineoplastic activity; tipiracil inhibits thymidine phosphorylase
Source
Med Lett Drugs Ther. 2016 Jun 6;58(1496):e77
Date of Entry
2017/01/30
Revision Date
2020/02/28
trifluridine tipiracil drug combination Preferred
TAS 102 Narrower
Lonsurf Narrower
page delivered in 0.004s